K Ray Chaudhuri

Summary

Country: UK

Publications

  1. ncbi request reprint The basis for day and night-time control of symptoms of Parkinson's disease
    K Ray Chaudhuri
    Regional Movement Disorders Unit, King s College Hospital, London, UK
    Eur J Neurol 9:40-3. 2002
  2. pmc Long duration asymmetrical postural tremor is likely to predict development of Parkinson's disease and not essential tremor: clinical follow up study of 13 cases
    K Ray Chaudhuri
    Department of Neurology, King s College Hospital, Denmark Hill, London, SE5 9RS, UK
    J Neurol Neurosurg Psychiatry 76:115-7. 2005
  3. pmc Motor and nonmotor complications in Parkinson's disease: an argument for continuous drug delivery?
    K Ray Chaudhuri
    National Parkinson Foundation Centre of Excellence and National RLS, King s College Hospital, 9th Floor Ruskin Wing, Denmark Hill, London, SE5 9RS, UK
    J Neural Transm 120:1305-20. 2013
  4. doi request reprint Rotigotine and specific non-motor symptoms of Parkinson's disease: post hoc analysis of RECOVER
    K Ray Chaudhuri
    National Parkinson Foundation Centre of Excellence, King s College Hospital, and MRC Centre for Neurodegeneration Research, King s College, London, UK
    Parkinsonism Relat Disord 19:660-5. 2013
  5. doi request reprint Parkinson's disease: the non-motor issues
    K Ray Chaudhuri
    National Parkinson Foundation Centre of Excellence, King s College Hospital, Kings College, Denmark Hill, London, UK
    Parkinsonism Relat Disord 17:717-23. 2011
  6. doi request reprint The challenge of non-motor symptoms in Parkinson's disease
    K Ray Chaudhuri
    National Parkinson Foundation Centre of Excellence, Kings College Hospital and University Hospital Lewisham, London, UK
    Prog Brain Res 184:325-41. 2010
  7. doi request reprint Improvements in nocturnal symptoms with ropinirole prolonged release in patients with advanced Parkinson's disease
    K Ray Chaudhuri
    National Parkinson Foundation Centre of Excellence, Kings College Hospital, Kings College and Institute of Psychiatry, London, UK
    Eur J Neurol 19:105-13. 2012
  8. doi request reprint Intrajejunal levodopa versus conventional therapy in Parkinson disease: motor and nonmotor effects
    Prashanth Reddy
    National Parkinson Foundation Centre of Excellence, King s College and Institute of Psychiatry, London, UK
    Clin Neuropharmacol 35:205-7. 2012
  9. doi request reprint Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
    K Ray Chaudhuri
    National Parkinson Foundation Centre of Excellence, King s College Hospital and University Hospital Lewisham, London, UK
    Lancet Neurol 8:464-74. 2009
  10. ncbi request reprint Non-motor symptoms: identification and management
    Sharon Muzerengi
    University Hospital Lewisham, National Parkinson Foundation Centre of Excellence, King s College, London, UK
    Parkinsonism Relat Disord 13:S450-6. 2007

Collaborators

Detail Information

Publications29

  1. ncbi request reprint The basis for day and night-time control of symptoms of Parkinson's disease
    K Ray Chaudhuri
    Regional Movement Disorders Unit, King s College Hospital, London, UK
    Eur J Neurol 9:40-3. 2002
    ....
  2. pmc Long duration asymmetrical postural tremor is likely to predict development of Parkinson's disease and not essential tremor: clinical follow up study of 13 cases
    K Ray Chaudhuri
    Department of Neurology, King s College Hospital, Denmark Hill, London, SE5 9RS, UK
    J Neurol Neurosurg Psychiatry 76:115-7. 2005
    ..Patients presenting with asymmetrical postural tremor with or without mild rest tremor may be diagnosed as having essential tremor (ET), although there is considerable diagnostic uncertainty as to the long term outcome of these patients...
  3. pmc Motor and nonmotor complications in Parkinson's disease: an argument for continuous drug delivery?
    K Ray Chaudhuri
    National Parkinson Foundation Centre of Excellence and National RLS, King s College Hospital, 9th Floor Ruskin Wing, Denmark Hill, London, SE5 9RS, UK
    J Neural Transm 120:1305-20. 2013
    ..Certainly, the complexities of optimal PD management, and the rationale for an underlying strategy such as CDS or CDD, have not yet been thoroughly elucidated. ..
  4. doi request reprint Rotigotine and specific non-motor symptoms of Parkinson's disease: post hoc analysis of RECOVER
    K Ray Chaudhuri
    National Parkinson Foundation Centre of Excellence, King s College Hospital, and MRC Centre for Neurodegeneration Research, King s College, London, UK
    Parkinsonism Relat Disord 19:660-5. 2013
    ..Rotigotine improved NMSS total score compared with placebo, and the "Sleep/fatigue" and "Mood/apathy" domains. This post hoc analysis further characterizes the effects of rotigotine on sleep/fatigue and mood/apathy...
  5. doi request reprint Parkinson's disease: the non-motor issues
    K Ray Chaudhuri
    National Parkinson Foundation Centre of Excellence, King s College Hospital, Kings College, Denmark Hill, London, UK
    Parkinsonism Relat Disord 17:717-23. 2011
    ..This review aims to address some of these topical and "real life" aspects of modern day management of Parkinson's...
  6. doi request reprint The challenge of non-motor symptoms in Parkinson's disease
    K Ray Chaudhuri
    National Parkinson Foundation Centre of Excellence, Kings College Hospital and University Hospital Lewisham, London, UK
    Prog Brain Res 184:325-41. 2010
    ..The American Academy of Neurology has recently published the first task force guidelines in relation to treatment of NMS of PD...
  7. doi request reprint Improvements in nocturnal symptoms with ropinirole prolonged release in patients with advanced Parkinson's disease
    K Ray Chaudhuri
    National Parkinson Foundation Centre of Excellence, Kings College Hospital, Kings College and Institute of Psychiatry, London, UK
    Eur J Neurol 19:105-13. 2012
    ..We investigated the effect of ropinirole prolonged release on nocturnal symptoms in these patients...
  8. doi request reprint Intrajejunal levodopa versus conventional therapy in Parkinson disease: motor and nonmotor effects
    Prashanth Reddy
    National Parkinson Foundation Centre of Excellence, King s College and Institute of Psychiatry, London, UK
    Clin Neuropharmacol 35:205-7. 2012
    ....
  9. doi request reprint Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
    K Ray Chaudhuri
    National Parkinson Foundation Centre of Excellence, King s College Hospital and University Hospital Lewisham, London, UK
    Lancet Neurol 8:464-74. 2009
    ..This Review provides a comprehensive overview of the management of this challenging aspect of PD...
  10. ncbi request reprint Non-motor symptoms: identification and management
    Sharon Muzerengi
    University Hospital Lewisham, National Parkinson Foundation Centre of Excellence, King s College, London, UK
    Parkinsonism Relat Disord 13:S450-6. 2007
    ..However, awareness that these symptoms are related to PD is vital as research into treatment and causation will be the cornerstone for delivering a comprehensive modern treatment for PD...
  11. doi request reprint Early Parkinson's disease and non-motor issues
    K Ray Chaudhuri
    Kings College Hospital, Denmark Hill, London, UK
    J Neurol 255:33-8. 2008
    ..The non motor quesionnaire (NMSQuest) and the recently validated NMS scale allow falgging and quantification of NMS of PD and therefore are important tools to comprehensively assess symptom load in PD...
  12. ncbi request reprint The range and nature of sleep dysfunction in untreated Parkinson's disease (PD). A comparative controlled clinical study using the Parkinson's disease sleep scale and selective polysomnography
    V Dhawan
    Regional Movement Disorders Unit, King s College Hospital, UK
    J Neurol Sci 248:158-62. 2006
    ..Furthermore, polysomnography in "sleepy" PD patients may help diagnose unrecognised conditions such as periodic limb movement of sleep (PLMS), obstructive sleep apnoea (OSA) and REM Sleep Behaviour Disorder...
  13. doi request reprint The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: an international study using the nonmotor symptoms questionnaire
    K Ray Chaudhuri
    National Parkinson Foundation Centre of Excellence, Kings College Hospital, Denmark Hill, London, United Kingdom
    Mov Disord 25:704-9. 2010
    ..Use of NMSQuest allows patients to flag symptoms which may be otherwise undeclared and remain untreated when potential treatments exist...
  14. ncbi request reprint The non-motor symptom complex of Parkinson's disease: a comprehensive assessment is essential
    K Ray Chaudhuri
    Neurology, Kings College Hospital, Ruskin Wing, Denmark Hill, London SE5 9RS, United Kindgom
    Curr Neurol Neurosci Rep 5:275-83. 2005
    ..Recently, an international, multidisciplinary PD-NMS group has developed an integrated questionnaire and scale to assess NMS of PD in a comprehensive manner. This will help improve care and treatment of PD in the future...
  15. ncbi request reprint Non-motor symptoms of Parkinson's disease: diagnosis and management
    K Ray Chaudhuri
    Movement Disorders Unit, Kings College Hospital, Guy s King s and St Thomas School of Medicine, London, UK
    Lancet Neurol 5:235-45. 2006
    ..Inevitably, the development of treatments that can slow or prevent the progression of Parkinson's disease and its multicentric neurodegeneration provides the best hope of curing non-motor symptoms...
  16. doi request reprint Quantitation of non-motor symptoms in Parkinson's disease
    K Ray Chaudhuri
    National Parkinson Foundation Centre of Excellence, King s College Hospital, University Hospital Lewisham, Kings College and Institute of Psychiatry, London, UK
    Eur J Neurol 15:2-7. 2008
    ....
  17. ncbi request reprint Use of the dopamine agonist cabergoline in the treatment of movement disorders
    Aimee Di Marco
    Movement Disorders Unit, Mapother House, King s College Hospital, Denmark Hill, London, UK
    Expert Opin Pharmacother 3:1481-7. 2002
    ..Audits of the clinical efficacy of cabergoline indicate that it is well-tolerated and has an acceptable side effect profile...
  18. ncbi request reprint The frequency and significance of 'striatal toe' in parkinsonism
    Andrea Sylvia Winkler
    Regional Movement Disorders and Autonomic Unit, King s College Hospital and Guy s, King s and St Thomas Medical School, London, UK
    Parkinsonism Relat Disord 9:97-101. 2002
    ..The possible relevance of these findings is discussed...
  19. ncbi request reprint Nocturnal symptom complex in PD and its management
    K Ray Chaudhuri
    Regional Movement Disorders Unit, King s College Hospital, University Hospital Lewisham, Guy s, King s and St Thomas School of Biomedical Medicine, King s College, London, United Kingdom
    Neurology 61:S17-23. 2003
  20. ncbi request reprint Clinical assessment of nocturnal disability in Parkinson's disease: the Parkinson's Disease Sleep Scale
    K Ray Chaudhuri
    Regional Movement Disorders Unit, King s College Hospital, University Hospital Lewisham, Guy s, King s and St Thomas School of Biomedical Medicine, King s College, London, United Kingdom
    Neurology 63:S17-20. 2004
  21. pmc Trial of CBT for impulse control behaviors affecting Parkinson patients and their caregivers
    David Okai
    Departments of Psychosis Studies, King s College Hospital, London
    Neurology 80:792-9. 2013
    ..To test the effects of a novel cognitive-behavioral therapy (CBT)-based intervention delivered by a nurse therapist to patients with Parkinson disease (PD) with clinically significant impulse control behaviors (ICB)...
  22. doi request reprint Dopamine receptor agonists and sleep disturbances in Parkinson's disease
    K Ray Chaudhuri
    National Parkinson Foundation Centre of Excellence, King s College Hospital, University Hospital Lewisham, London, UK
    Parkinsonism Relat Disord 15:S101-4. 2009
    ..In this review, we discuss how dopamine receptor agonists can both ameliorate and aggravate the sleep problems in PD, a key non-motor symptom of this disease...
  23. ncbi request reprint Sleep-related problems of Parkinson's disease
    V Dhawan
    Movement Disorders Unit, Kings College Hospital, University Hospital Lewisham, Guy s King s and St Thomas School of Medicine, London, UK
    Age Ageing 35:220-8. 2006
    ..To define the epidemiology, characteristics and aetiology of nocturnal symptoms and sleep disorders in patients with Parkinson's disease (PD) and evaluate the available methods for their diagnosis and management...
  24. pmc The possible clinical predictors of fatigue in Parkinson's disease: a study of 135 patients as part of international nonmotor scale validation project
    Vinod Metta
    National Parkinson Foundation Centre of Excellence, King s College Hospital, King s College London, Denmark Hill Campus, 9th Floor, Ruskin Wing, gt London SE5 9RS, UK
    Parkinsons Dis 2011:125271. 2011
    ..In a cohort of patients from a range of disease stages, occurrence of fatigue correlated closely with more advanced Parkinson's disease, as well as with depression, anxiety, and sleep disorders, hinting at a common underlying basis...
  25. doi request reprint Sleep dysfunction and role of dysautonomia in Parkinson's disease
    Tanya Mitra
    King s College London School of Medicine, London, UK
    Parkinsonism Relat Disord 15:S93-5. 2009
    ..Restless legs syndrome and sleep disordered breathing can all affect daytime alertness of PD patients. Autonomic deregulation can also negatively affect sleep patterns, by adding to night-time wakening and disrupting sleep...
  26. ncbi request reprint Serum prolactin levels in Parkinson's disease and multiple system atrophy
    Andrea Sylvia Winkler
    Consultant Neurologist, King s College Hospital, Mapother House, Denmark Hill, London SE5 9RS, UK ray chaudhuri kingshc nhs
    Clin Auton Res 12:393-8. 2002
    ..Baseline PRL levels might differentiate between early MSA and IPD, being higher in MSA. However, orthostatic stress using HUT appears unable to differentiate between MSA and IPD...
  27. doi request reprint [¹⁸F]FDOPA uptake in the raphe nuclei complex reflects serotonin transporter availability. A combined [¹⁸F]FDOPA and [¹¹C]DASB PET study in Parkinson's disease
    N Pavese
    Centre for Neuroscience, Department of Medicine, Imperial College, London, UK
    Neuroimage 59:1080-4. 2012
    ..These findings provide evidence that [(18)F]FDOPA PET represents a valid marker of raphe serotoninergic function in PD and supports previous studies where [(18)F]FDOPA PET has been used to assess serotoninergic function in PD...
  28. ncbi request reprint Diagnosing restless legs syndrome (RLS) in primary care
    K Ray Chaudhuri
    Kings College and University Hospital Lewisham, London, UK
    Curr Med Res Opin 20:1785-95. 2004
    ....
  29. doi request reprint Symptom prevalence, severity and palliative care needs assessment using the Palliative Outcome Scale: a cross-sectional study of patients with Parkinson's disease and related neurological conditions
    Tariq Z Saleem
    Department of Clinical Neuroscience, Institute of Psychiatry, King s College London, London, UK
    Palliat Med 27:722-31. 2013
    ..Palliative care is rarely being offered to patients with Parkinson's disease...